BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29382658)

  • 1. Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort.
    Hunt KJ; Jaffa MA; Garrett SM; Luttrell DK; Lipson KE; Lopes-Virella MF; Luttrell LM; Jaffa AA;
    Diabetes Care; 2018 Apr; 41(4):840-846. PubMed ID: 29382658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
    Lopes-Virella MF; Hunt KJ; Baker NL; Virella G; Moritz T;
    Atherosclerosis; 2012 Oct; 224(2):526-31. PubMed ID: 22963984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma CTGF is independently related to an increased risk of cardiovascular events and mortality in patients with atherosclerotic disease: the SMART study.
    Gerritsen KG; Falke LL; van Vuuren SH; Leeuwis JW; Broekhuizen R; Nguyen TQ; de Borst GJ; Nathoe HM; Verhaar MC; Kok RJ; Goldschmeding R; Visseren FL;
    Growth Factors; 2016 Aug; 34(3-4):149-58. PubMed ID: 27686612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial.
    Florez H; Reaven PD; Bahn G; Moritz T; Warren S; Marks J; Reda D; Duckworth W; Abraira C; Hayward R; Emanuele N;
    Diabetes Obes Metab; 2015 Oct; 17(10):949-55. PubMed ID: 25964070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial.
    Alele JD; Luttrell LM; Hollis BW; Luttrell DK; Hunt KJ;
    Atherosclerosis; 2013 Jun; 228(2):502-7. PubMed ID: 23608249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor beta type 1 (TGF-beta1) at the utero-placental interface during early pregnancy in the pig.
    Moussad EE; Rageh MA; Wilson AK; Geisert RD; Brigstock DR
    Mol Pathol; 2002 Jun; 55(3):186-92. PubMed ID: 12032230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF).
    Kono M; Nakamura Y; Suda T; Kato M; Kaida Y; Hashimoto D; Inui N; Hamada E; Miyazaki O; Kurashita S; Fukamachi I; Endo K; Ng PS; Takehara K; Nakamura H; Maekawa M; Chida K
    Clin Chim Acta; 2011 Nov; 412(23-24):2211-5. PubMed ID: 21864521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins.
    Heng EC; Huang Y; Black SA; Trackman PC
    J Cell Biochem; 2006 May; 98(2):409-20. PubMed ID: 16440322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Connective Tissue Growth Factor (CTGF/CCN2) with Hepatic Fibrosis in Chronic Hepatitis B.
    Ferdoushi S; Paul D; Ghosh CK; Sultana T; Joarder AI; Islam MS; Islam MS; Mahmuduzzaman M; Rahman Q; Ahmed AN
    Mymensingh Med J; 2015 Jul; 24(3):558-63. PubMed ID: 26329955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transforming growth factor-beta1 on expression of the connective tissue growth factor (CCN2/CTGF) gene in normal human gingival fibroblasts and periodontal ligament cells.
    Takeuchi H; Kubota S; Murakashi E; Fukada T; Hashimoto S; Takigawa M; Numabe Y
    J Periodontal Res; 2009 Apr; 44(2):161-9. PubMed ID: 19210343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCN family 2/connective tissue growth factor (CCN2/CTGF) stimulates proliferation and differentiation of auricular chondrocytes.
    Fujisawa T; Hattori T; Ono M; Uehara J; Kubota S; Kuboki T; Takigawa M
    Osteoarthritis Cartilage; 2008 Jul; 16(7):787-95. PubMed ID: 18289887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
    Mohammedi K; Bellili-Muñoz N; Marklund SL; Driss F; Le Nagard H; Patente TA; Fumeron F; Roussel R; Hadjadj S; Marre M; Velho G
    Cardiovasc Diabetol; 2015 Jan; 14():845. PubMed ID: 25855220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidal regulation of connective tissue growth factor (CCN2; CTGF) synthesis in the mouse uterus.
    Rageh MA; Moussad EE; Wilson AK; Brigstock DR
    Mol Pathol; 2001 Oct; 54(5):338-46. PubMed ID: 11577177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.
    Nguyen TQ; Tarnow L; Jorsal A; Oliver N; Roestenberg P; Ito Y; Parving HH; Rossing P; van Nieuwenhoven FA; Goldschmeding R
    Diabetes Care; 2008 Jun; 31(6):1177-82. PubMed ID: 18344285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CTGF/CCN2 on osteo/cementoblastic and fibroblastic differentiation of a human periodontal ligament stem/progenitor cell line.
    Yuda A; Maeda H; Fujii S; Monnouchi S; Yamamoto N; Wada N; Koori K; Tomokiyo A; Hamano S; Hasegawa D; Akamine A
    J Cell Physiol; 2015 Jan; 230(1):150-9. PubMed ID: 24905848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.
    Aoyama E; Hattori T; Hoshijima M; Araki D; Nishida T; Kubota S; Takigawa M
    Biochem J; 2009 May; 420(3):413-20. PubMed ID: 19298220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction.
    Ritschel V; Shetelig C; Seljeflot I; Limalanathan S; Hoffmann P; Halvorsen S; Arnesen H; Eritsland J; Andersen GØ
    Sci Rep; 2017 Sep; 7(1):11945. PubMed ID: 28931920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.
    Kovalenko E; Tacke F; Gressner OA; Zimmermann HW; Lahme B; Janetzko A; Wiederholt T; Berg T; Müller T; Trautwein C; Gressner AM; Weiskirchen R
    J Viral Hepat; 2009 Sep; 16(9):612-20. PubMed ID: 19243500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ.
    Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P
    Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases.
    Gonzalez D; Brandan E
    Mol Neurobiol; 2019 Aug; 56(8):5911-5916. PubMed ID: 30689195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.